Cargando…
Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial
BACKGROUND: Metformin has favorable effects on cardiovascular outcomes in both newly onset and advanced type 2 diabetes, as previously reported findings from the UK Prospective Diabetes Study and the HOME trial have demonstrated. Patients with type 2 diabetes present with chronically elevated circul...
Autores principales: | Stultiens, Johanna M. G., Top, Wiebe M. C., Kimenai, Dorien M., Lehert, Philippe, Bekers, Otto, Stehouwer, Coen D. A., Kooy, Adriaan, Meex, Steven J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981770/ https://www.ncbi.nlm.nih.gov/pubmed/35379238 http://dx.doi.org/10.1186/s12933-022-01482-z |
Ejemplares similares
-
Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial
por: Top, Wiebe M. C., et al.
Publicado: (2021) -
Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
por: Top, Wiebe M. C., et al.
Publicado: (2022) -
Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry
por: Kimenai, Dorien M., et al.
Publicado: (2020) -
Biotin interference in high-sensitivity cardiac troponin T testing: a
real-world evaluation in acute cardiac care
por: Vroemen, Wim H M, et al.
Publicado: (2019) -
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial
por: de Jager, Jolien, et al.
Publicado: (2010)